Lithium Carbonate
Therapeutic agent (verify pharmacological class)
What it is used for
Maniac episodes of maniac depressive-illness. Clinical selection for Lithium Carbonate should follow culture results where relevant, Kenya STG/EML recommendations, and the current product SmPC. Class context: Therapeutic agent (verify pharmacological class). Confirm site-specific dose, duration and monitoring before prescribing.
Warnings
Concomitant infection with pyrexia; monitor thyroid function [it may be induce latent hypothyroidism in predisposed or elderly patients]; maintain adequate fluid intake; regular lithium serum determination; diuretic therapy.
Possible side effects
Adverse reactions vary by agent. Counsel on common predictable effects and serious warning symptoms (allergy, severe rash, jaundice, unusual bleeding, severe GI symptoms, neurological changes). Report suspected ADRs via national pharmacovigilance channels.
Storage
Store as labelled. Keep out of reach of children.
No reviewed patient-education article is available. The fields shown are from the currently verified medicine record and unavailable fields are not inferred.